Elton Rexhepaj

4.1k citations

35 papers · 2.9k indexed · 1 hit paper · h-index 21

Oncology top 2%
Molecular Biology top 10%
Immunology top 2%
Cancer Research top 5%
Pulmonary and Respiratory Medicine top 10%

Co-authors: William M. Gallagher Donal J. Brennan Karin Jirström Stephen F. Madden Lisa M. Coussens David G. DeNardo Brian Ruffell E. Shelley Hwang
Topics: Cell Image Analysis Techniques (12 papers)HER2/EGFR in Cancer Research (5 papers)Gene expression and cancer classification (5 papers)
Cited by: Immunology Oncology Biophysics
Journals: Proceedings of the National Academy of Sciences Nature Communications Journal of Clinical Oncology
Partner nations: Ireland Sweden United States

In The Last Decade

Elton Rexhepaj

33 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy

2011 1.3k citations David G. DeNardo, Donal J. Brennan et al. Cancer Discovery profile →

Peers

Countries citing papers authored by Elton Rexhepaj

Since Specialization

Citations

This map shows the geographic impact of Elton Rexhepaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elton Rexhepaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elton Rexhepaj more than expected).

Fields of papers citing papers by Elton Rexhepaj

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elton Rexhepaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elton Rexhepaj. The network helps show where Elton Rexhepaj may publish in the future.

Co-authorship network of co-authors of Elton Rexhepaj

This figure shows the co-authorship network connecting the top 25 collaborators of Elton Rexhepaj. A scholar is included among the top collaborators of Elton Rexhepaj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elton Rexhepaj. Elton Rexhepaj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Compound Functional Prediction Using Multiple Unrelated Morphological Profiling Assays 2017 ·SLAS TECHNOLOGY ·(unknown),Sreetama Basu,Elton Rexhepaj,Anne Chauchereau,Elaine Del Nery,Auguste Genovesio	12
2	Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer 2015 ·QUT ePrints (Queensland University of Technology) ·Dermot S. O’Callaghan,Elton Rexhepaj,Kathy Gately,Linda Coate,David Delaney,Dearbhaile M. O’Donnell,Elaine W. Kay,Finbarr O’Connell,William M. Gallagher,Kenneth J. O’Byrne	3
3	Tumour islet Foxp3⁺T-cell infiltration predicts poor outcome in nonsmall cell lung cancer 2015 ·European Respiratory Journal ·Dermot S. O’Callaghan,Elton Rexhepaj,Kathy Gately,Linda Coate,David Delaney,Dearbhaile M. O’Donnell,Elaine W. Kay,Finbarr O’Connell,William M. Gallagher,Kenneth J. O’Byrne	55
4	Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer 2013 ·BMC Cancer ·(unknown),Sarah Penny,Róisín Dolan,Catherine M. Kelly,Stephen F. Madden,Elton Rexhepaj,Donal J. Brennan,Amanda McCann,Fredrik Pontén,Mathias Uhlén,Radosław Zagożdżon,Michael J. Duffy,Malcolm Kell,Karin Jirström,William M. Gallagher	43
5	Immunofluorescence and fluorescent-protein tagging show high correlation for protein localization in mammalian cells 2013 ·Nature Methods ·Charlotte Stadler,Elton Rexhepaj,Vasanth Singan,Robert F. Murphy,Rainer Pepperkok,Mathias Uhlén,Jeremy C. Simpson,Emma Lundberg	201
6	A Texture Based Pattern Recognition Approach to Distinguish Melanoma from Non-Melanoma Cells in Histopathological Tissue Microarray Sections 2013 ·PLoS ONE ·Elton Rexhepaj,Margrét Agnarsdóttir,Julia Bergman,Per‐Henrik Edqvist,Michael Bergqvist,Mathias Uhlén,William M. Gallagher,Emma Lundberg,Fredrik Pontén	18
7	Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapybreakdown → 2011 ·Cancer Discovery ·David G. DeNardo,Donal J. Brennan,Elton Rexhepaj,Brian Ruffell,Stephen L. Shiao,Stephen F. Madden,William M. Gallagher,(unknown),(unknown),(unknown),Hope S. Rugo,E. Shelley Hwang,Karin Jirström,Brian L. West,Lisa M. Coussens	1320
8	Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer 2011 ·Clinical Cancer Research ·Jermaine Coward,Hagen Kulbe,Probir Chakravarty,David P. Leader,Vessela Vassileva,David A. Leinster,R. Thompson,Tiziana Schioppa,(unknown),Jessica Vermeulen,Naveena Singh,Norbert Avril,Jeff Cummings,Elton Rexhepaj,Karin Jirström,William M. Gallagher,Donal J. Brennan,Iain A. McNeish,Frances R. Balkwill	313
9	The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ERα, and is an independent prognostic factor in node-negative breast cancer 2011 ·Oncogene ·Donal J. Brennan,Darran P. O’Connor,(unknown),Sharon F. McGee,Sean McCarthy,Radosław Zagożdżon,Elton Rexhepaj,Aedín C. Culhane,F. Martin,Michael J. Duffy,G. Landberg,Lisa Rydén,Stephen M. Hewitt,M. J. Kuhar,René Bernards,Robert C. Millikan,John Crown,Karin Jirström,William M. Gallagher	9
10	The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation 2011 ·BMC Cancer ·Sandra Sernbo,(unknown),Donal J. Brennan,William M. Gallagher,Elton Rexhepaj,(unknown),Karin Jirström,Carl Borrebaeck,Sara Ek	46
11	Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis 2011 ·Modern Pathology ·Anna Dahlman,Elton Rexhepaj,Donal J. Brennan,William M. Gallagher,Alexander Gaber,Anna Lindgren,Karin Jirström,Anders Bjartell	29
12	Identification of a myometrial molecular profile for dystocic labor 2011 ·BMC Pregnancy and Childbirth ·Donal J. Brennan,Sharon F. McGee,Elton Rexhepaj,Darran P. O’Connor,Michael Robson,Colm O’Herlihy	10
13	Receptor Tyrosine Kinase Signaling Favors a Protumorigenic State in Breast Cancer Cells by Inhibiting the Adaptive Immune Response 2010 ·Cancer Research ·Josie Ursini‐Siegel,Sean Cory,Dongmei Zuo,W. Rod Hardy,Elton Rexhepaj,Sonya H.L. Lam,Babette Schade,Karin Jirström,Eva Bjur,Ciriaco A. Piccirillo,David G. DeNardo,Lisa M. Coussens,Donal J. Brennan,William M. Gallagher,Morag Park,Tony Pawson,Michael Hallett,William J. Muller	24
14	SOX10 expression in superficial spreading and nodular malignant melanomas 2010 ·Melanoma Research ·Margrét Agnarsdóttir,Linda Sooman,(unknown),Sara Strömberg,Elton Rexhepaj,Michael Bergqvist,Fredrik Pontén,William M. Gallagher,Johan Lennartsson,Simon Ekman,Mathias Uhlén,Håkan Hedstrand	26
15	Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer 2010 ·BMC Cancer ·Elton Rexhepaj,Karin Jirström,Darran P. O’Connor,Sallyann L. O’Brien,Göran Landberg,Michael J. Duffy,Donal J. Brennan,William M. Gallagher	38
16	Tissue Microarrays and Digital Image Analysis 2010 ·Methods in molecular biology ·(unknown),Laoighse Mulrane,Elton Rexhepaj,William M. Gallagher	6
17	Altered Cytoplasmic-to-Nuclear Ratio of Survivin Is a Prognostic Indicator in Breast Cancer 2008 ·Clinical Cancer Research ·Donal J. Brennan,Elton Rexhepaj,Sallyann L. O’Brien,Elaine McSherry,Darran P. O’Connor,Ailís Fagan,Aedín C. Culhane,Desmond G. Higgins,Karin Jirström,Robert C. Millikan,Göran Landberg,Michael J. Duffy,Stephen M. Hewitt,William M. Gallagher	71
18	Automated image analysis in histopathology: a valuable tool in medical diagnostics 2008 ·Expert Review of Molecular Diagnostics ·Laoighse Mulrane,Elton Rexhepaj,(unknown),John J. Callanan,William M. Gallagher	98
19	Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer 2008 ·Breast Cancer Research ·Elton Rexhepaj,Donal J. Brennan,Peter J. Holloway,Elaine W. Kay,Amanda McCann,Göran Landberg,Michael J. Duffy,Karin Jirström,William M. Gallagher	106
20	Combination of SELDI-TOF-MS and Data Mining Provides Early-stage Response Prediction for Rectal Tumors Undergoing Multimodal Neoadjuvant Therapy 2007 ·Annals of Surgery ·F. M. Smith,William M. Gallagher,Edward Fox,R. B. Stephens,Elton Rexhepaj,Emanuel F. Petricoin,Lance A. Liotta,Megan Kennedy,John V. Reynolds	55

About Elton Rexhepaj

Elton Rexhepaj is a scholar working on Biophysics, Structural Biology and Oncology, having authored 35 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cell Image Analysis Techniques (12 papers), HER2/EGFR in Cancer Research (5 papers) and Gene expression and cancer classification (5 papers). The work is most often cited by research in Immunology (1.2k citations), Oncology (1.3k citations) and Biophysics (219 citations). Elton Rexhepaj has collaborated with scholars based in Ireland, Sweden and United States. Frequent co-authors include William M. Gallagher, Donal J. Brennan, Karin Jirström, Stephen F. Madden, Lisa M. Coussens, David G. DeNardo, Brian Ruffell, E. Shelley Hwang, Brian L. West and Hope S. Rugo. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact